These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 15659871)

  • 1. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry.
    Badhe PB; Chauhan PP; Mehta NK
    Indian J Cancer; 2004; 41(4):170-4. PubMed ID: 15659871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features of human brainstem gliomas.
    Oka H; Utsuki S; Tanizaki Y; Hagiwara H; Miyajima Y; Sato K; Kusumi M; Kijima C; Fujii K
    Brain Tumor Pathol; 2013 Jan; 30(1):1-7. PubMed ID: 22484454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical considerations for 'intrinsic' brainstem gliomas: proposal of a modification in classification.
    Mehta VS; Chandra PS; Singh PK; Garg A; Rath GK
    Neurol India; 2009; 57(3):274-81. PubMed ID: 19587467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain stem gliomas: a clinicopathological study from a single cancer center.
    Al-Hussaini M; Al-Jumaily U; Swaidan M; Musharbash A; Hashem S
    Brain Tumor Pathol; 2013 Apr; 30(2):84-92. PubMed ID: 22752621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
    Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
    von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S
    Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
    Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of p53 immunoreactivity in patients with glioma.
    Kyritsis AP; Bondy ML; Hess KR; Cunningham JE; Zhu D; Amos CJ; Yung WK; Levin VA; Bruner JM
    Clin Cancer Res; 1995 Dec; 1(12):1617-22. PubMed ID: 9815964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord malignant astrocytomas. Clinicopathologic features in 36 cases.
    Santi M; Mena H; Wong K; Koeller K; Olsen C; Rushing EJ
    Cancer; 2003 Aug; 98(3):554-61. PubMed ID: 12879473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brainstem gliomas--retrospective analysis of 86 patients.
    Ueoka DI; Nogueira J; Campos JC; Maranhão Filho P; Ferman S; Lima MA
    J Neurol Sci; 2009 Jun; 281(1-2):20-3. PubMed ID: 19345380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma.
    Gilbertson RJ; Hill DA; Hernan R; Kocak M; Geyer R; Olson J; Gajjar A; Rush L; Hamilton RL; Finkelstein SD; Pollack IF
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3620-4. PubMed ID: 14506149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF; Prayson RA; Barnett GH; Weil RJ
    Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinicopathological study of nine cases of midbrain glioma].
    Nitta T; Sato K
    No Shinkei Geka; 1995 May; 23(5):405-10. PubMed ID: 7753319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM
    Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.